Hyperion Therapeutics to Present at the Oppenheimer 25th Annual Healthcare Conference
December 04, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Oppenheimer 25th Annual Healthcare...
Hyperion Therapeutics to Present at the Jefferies 2014 Global London Healthcare Conference
November 13, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Jefferies 2014 Global London Healthcare...
Hyperion Therapeutics Announces Third Quarter 2014 Financial Results
November 06, 2014 16:00 ET
|
Hyperion Therapeutics, Inc.
-- UCD Product Portfolio Generates $26.2 Million in Net Sales During the Quarter --
-- Company Delivers Fifth Consecutive Quarter of Adjusted Net Income --
-- Company to Host Conference Call...
Hyperion Therapeutics to Report Third Quarter 2014 Financial Results After Market on November 6, 2014
October 31, 2014 09:00 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Oct. 31, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that it will report third quarter 2014 financial results after market close on Thursday,...
Hyperion Therapeutics and Clal Biotechnology Industries Ltd. Enter Into Interim Agreement
BRISBANE, Calif. and RAMAT GAN, Israel, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) ("Hyperion") and Clal Biotechnology Industries Ltd. (TASE:CBI) ("CBI") today...
Hyperion Therapeutics to Present at the Leerink Rare Disease Roundtable
September 24, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Sept. 24, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the company is scheduled to present at the Leerink Rare Disease Roundtable on...
Hyperion Therapeutics to Host Analyst Day September 30, 2014
September 23, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced that the Company will hold an Analyst Day on Tuesday, September 30, 2014, from 9:00 a.m....
Hyperion Therapeutics Terminates DiaPep277(R) Program
September 08, 2014 08:00 ET
|
Hyperion Therapeutics, Inc.
Company Discovers Serious Misconduct by Andromeda Biotech Ltd.
Company to Host Conference Call Today at 9:00 a.m. ET (6:00 a.m. PT)
BRISBANE, Calif., Sept. 8, 2014 (GLOBE NEWSWIRE) -- Hyperion...
Hyperion Therapeutics Appoints Theodore Schroeder to Board of Directors
August 12, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
BRISBANE, Calif., Aug. 12, 2014 (GLOBE NEWSWIRE) -- Hyperion Therapeutics, Inc. (Nasdaq:HPTX) today announced the appointment of Theodore "Ted" Schroeder to its board of directors effective August 11,...
Hyperion Therapeutics Announces Second Quarter 2014 Financial Results
August 07, 2014 16:05 ET
|
Hyperion Therapeutics, Inc.
UCD Product Portfolio Generates $37.1 Million in Net Sales During the Quarter
--$31.6 million of RAVICTI® recognized in the quarter including $11.7 million of previously deferred...